Patrick G Gavin Selected Research

Patrick G Gavin Research Topics

10	Neoplasms (Cancer) 10/2020 - 03/2010
8	Breast Neoplasms (Breast Cancer) 10/2020 - 12/2013
5	Colonic Neoplasms (Colon Cancer) 02/2024 - 03/2010
3	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 09/2016
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2018 - 01/2018
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 04/2024
1	Dysbiosis 01/2021
1	Infections 01/2021
1	Pathologic Complete Response 12/2019
1	Diarrhea 12/2019
1	Disease Progression 10/2018
1	Inflammation (Inflammations) 10/2018
1	Microsatellite Instability 12/2012

8	Trastuzumab (Herceptin)FDA Link 10/2020 - 12/2013
6	B 31IBA 10/2020 - 12/2013
4	Oxaliplatin (Eloxatin)FDA LinkGeneric 02/2024 - 12/2012
3	neratinibIBA 01/2021 - 12/2019
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2020 - 03/2017
2	Leucovorin (Folinic Acid)FDA Link 02/2024 - 09/2016
2	Fluorouracil (Carac)FDA LinkGeneric 02/2024 - 09/2016
2	Hormones (Hormone)IBA 12/2019 - 12/2019
2	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2019 - 03/2017
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2019 - 03/2017
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 04/2015
1	anifrolumabIBA 04/2024
1	Interferon Type IIBA 04/2024
1	Volatile Fatty AcidsIBA 01/2021
1	Acetates (Acetic Acid Esters)FDA Link 01/2021
1	Panitumumab (Vectibix)FDA Link 01/2021
1	Cetuximab (Erbitux)FDA Link 01/2021
1	Butyrates (Butyrate)IBA 01/2021
1	Progesterone Receptors (Progesterone Receptor)IBA 10/2020
1	Estrogen ReceptorsIBA 10/2020
1	ErbB Receptors (EGF Receptor)IBA 12/2019
1	AutoantibodiesIBA 10/2018
1	Proteins (Proteins, Gene)FDA Link 10/2018
1	AntigensIBA 01/2018
1	Immunoglobulin G (IgG)IBA 01/2018
1	human ERBB2 proteinIBA 04/2015
1	Formaldehyde (Formol)FDA Link 03/2010
1	ParaffinIBA 03/2010
1	NucleotidesIBA 03/2010

8	Therapeutics 02/2024 - 04/2015
7	Drug Therapy (Chemotherapy) 10/2020 - 09/2016
1	Adjuvant Chemotherapy 12/2019
1	Investigational Therapies (Experimental Therapy) 09/2016